The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study

The purpose of this study was to investigate the cardioprotective effect of the semisynthetic flavonoid 7-monohydroxyethylrutoside (monoHER) on doxorubicin (DOX)-induced cardiotoxicity in a phase II study in patients with metastatic cancer. Eight patients with metastatic cancer were treated with DOX...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruynzeel, A M E, Niessen, H W M, Bronzwaer, J G F, van der Hoeven, J J M, Berkhof, J, Bast, A, van der Vijgh, W J F, van Groeningen, C J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360436/
https://www.ncbi.nlm.nih.gov/pubmed/17940501
http://dx.doi.org/10.1038/sj.bjc.6603994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360436/
https://www.ncbi.nlm.nih.gov/pubmed/17940501
http://dx.doi.org/10.1038/sj.bjc.6603994

Ejemplares similares